Skip to content
Disclosery

Alphabet Inc.

Follow

13F filer, CIK 1652044, Mountain View, CA

Alphabet Inc. reported $99,082,057,675 across 28 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-07. Its ten largest share positions make up 99.54% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001652044-26-000073

Period
2026-06-30
Reported value
$99.1B
Holdings
28
Top 10 weight
99.54%
New
3
Sold out
1

Part of the filer group Alphabet Inc.

How groups are built

Stakes and trades reported after 2026-06-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • WULF TERAWULF INC: 13G 41,011,803 shares, 7.6% of the class, 13G filed 2026-09-25, 0001193125-26-402852Timeline
    Accepted , ingested

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SPCXnew+551,189,500$94.2B
PBLSnew+4,919,498$135M
FRVOnew+1,760,732$51.5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
RVMDreduced-345,906-$64.8M
GLUEreduced-311,801-$7.55M
RLAYreduced-154,144-$2.88M
LIFEreduced-147,552-$2.68M
TNYAexited-915,705-$632K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001652044-26-000073, largest first. % of portfolio is the value over $99,082,057,675, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SPCXSPACE EXPLORATION TECHN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 551,189,500 shares 551,189,500$94.2B95.05%newTimeline
PLPLANET LABS PBCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 31,942,641 shares; 2024Q4: 31,942,641 shares; 2025Q1: 31,942,641 shares; 2025Q2: 31,942,641 shares; 2025Q3: 31,942,641 shares; 2025Q4: 31,942,641 shares; 2026Q1: 35,248,893 shares; 2026Q2: 35,248,893 shares 35,248,893$1.17B1.18%0Timeline
ASTSAST SPACEMOBILE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 8,943,486 shares; 2025Q2: 8,943,486 shares; 2025Q3: 8,943,486 shares; 2025Q4: 8,943,486 shares; 2026Q1: 8,943,486 shares; 2026Q2: 8,943,486 shares 8,943,486$795M0.8%0Timeline
CMECME GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,484,020 shares; 2026Q2: 3,484,020 shares 3,484,020$769M0.78%0Timeline
ARMARM HOLDINGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,960,784 shares; 2024Q4: 1,960,784 shares; 2025Q1: 1,960,784 shares; 2025Q2: 1,960,784 shares; 2025Q3: 1,960,784 shares; 2025Q4: 1,960,784 shares; 2026Q1: 1,960,784 shares; 2026Q2: 1,960,784 shares 1,960,784$695M0.7%0Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 4,256,175 shares; 2024Q4: 4,133,277 shares; 2025Q1: 4,133,277 shares; 2025Q2: 4,133,277 shares; 2025Q3: 4,133,277 shares; 2025Q4: 3,345,102 shares; 2026Q1: 3,292,525 shares; 2026Q2: 2,946,619 shares 2,946,619$552M0.56%-345,906Timeline
FRSHFRESHWORKS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 16,206,643 shares; 2024Q4: 16,206,643 shares; 2025Q1: 16,206,643 shares; 2025Q2: 16,206,643 shares; 2025Q3: 16,206,643 shares; 2025Q4: 16,206,643 shares; 2026Q1: 16,206,643 shares; 2026Q2: 16,206,643 shares 16,206,643$164M0.17%0Timeline
PBLSPARABILIS MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 4,919,498 shares 4,919,498$135M0.14%newTimeline
TEMTEMPUS AI INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,551,102 shares; 2024Q4: 1,551,102 shares; 2025Q1: 1,551,102 shares; 2025Q2: 1,551,102 shares; 2025Q3: 1,551,102 shares; 2025Q4: 1,551,102 shares; 2026Q1: 1,551,102 shares; 2026Q2: 1,551,102 shares 1,551,102$89.9M0.09%0Timeline
GTLBGITLAB INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 9,758,333 shares; 2024Q4: 6,091,238 shares; 2025Q1: 2,724,712 shares; 2025Q2: 2,724,712 shares; 2025Q3: 2,724,712 shares; 2025Q4: 2,724,712 shares; 2026Q1: 2,724,712 shares; 2026Q2: 2,724,712 shares 2,724,712$83.2M0.08%0Timeline
PATHUIPATH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 7,034,337 shares; 2024Q4: 7,034,337 shares; 2025Q1: 7,034,337 shares; 2025Q2: 7,034,337 shares; 2025Q3: 7,034,337 shares; 2025Q4: 7,034,337 shares; 2026Q1: 7,034,337 shares; 2026Q2: 7,034,337 shares 7,034,337$76.5M0.08%0Timeline
LIFEETHOS TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,770,156 shares; 2026Q2: 3,622,604 shares 3,622,604$65.7M0.07%-147,552Timeline
PRMEPRIME MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 15,062,498 shares; 2024Q4: 15,062,498 shares; 2025Q1: 15,062,498 shares; 2025Q2: 15,062,498 shares; 2025Q3: 16,562,498 shares; 2025Q4: 16,562,498 shares; 2026Q1: 16,562,498 shares; 2026Q2: 16,562,498 shares 16,562,498$61.1M0.06%0Timeline
FRVOFERVO ENERGY COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,760,732 shares 1,760,732$51.5M0.05%newTimeline
PAYPPAYPAY CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,125,000 shares; 2026Q2: 3,125,000 shares 3,125,000$44.8M0.05%0Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 2,412,471 shares; 2025Q2: 2,412,471 shares; 2025Q3: 2,412,471 shares; 2025Q4: 1,388,583 shares; 2026Q1: 1,388,583 shares; 2026Q2: 1,388,583 shares 1,388,583$41.4M0.04%0Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,568,753 shares; 2024Q4: 1,568,753 shares; 2025Q1: 1,568,753 shares; 2025Q2: 1,568,753 shares; 2025Q3: 1,568,753 shares; 2025Q4: 1,568,753 shares; 2026Q1: 1,564,173 shares; 2026Q2: 1,410,029 shares 1,410,029$26.4M0.03%-154,144Timeline
BBOTBRIDGEBIO ONCOLOGY THERAPEUTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,823,126 shares; 2025Q4: 2,823,126 shares; 2026Q1: 2,823,126 shares; 2026Q2: 2,823,126 shares 2,823,126$21.5M0.02%0Timeline
OSCROSCAR HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 481,988 shares; 2024Q4: 481,988 shares; 2025Q1: 481,988 shares; 2025Q2: 481,988 shares; 2025Q3: 481,988 shares; 2025Q4: 481,988 shares; 2026Q1: 481,988 shares; 2026Q2: 481,988 shares 481,988$13.7M0.01%0Timeline
BEAMBEAM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 321,604 shares; 2024Q4: 321,604 shares; 2025Q1: 321,604 shares; 2025Q2: 321,604 shares; 2025Q3: 321,604 shares; 2025Q4: 321,604 shares; 2026Q1: 321,604 shares; 2026Q2: 321,604 shares 321,604$11M0.01%0Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 241,264 shares; 2024Q4: 241,264 shares; 2025Q1: 241,264 shares; 2025Q2: 241,264 shares; 2025Q3: 241,264 shares; 2025Q4: 241,264 shares; 2026Q1: 241,264 shares; 2026Q2: 241,264 shares 241,264$10.4M0.01%0Timeline
SANASANA BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,812,500 shares; 2024Q4: 2,812,500 shares; 2025Q1: 2,812,500 shares; 2025Q2: 2,812,500 shares; 2025Q3: 2,812,500 shares; 2025Q4: 2,812,500 shares; 2026Q1: 2,812,500 shares; 2026Q2: 2,812,500 shares 2,812,500$9.82M0.01%0Timeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,464,015 shares; 2024Q4: 1,464,015 shares; 2025Q1: 1,464,015 shares; 2025Q2: 1,464,015 shares; 2025Q3: 1,464,015 shares; 2025Q4: 744,948 shares; 2026Q1: 684,275 shares; 2026Q2: 372,474 shares 372,474$9.01M0.01%-311,801Timeline
LYELLYELL IMMUNOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 293,256 shares; 2025Q3: 293,256 shares; 2025Q4: 293,256 shares; 2026Q1: 293,256 shares; 2026Q2: 293,256 shares 293,256$4.12M<0.01%0Timeline
FIGFIGMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 215,582 shares; 2025Q4: 215,582 shares; 2026Q1: 215,582 shares; 2026Q2: 215,582 shares 215,582$3.9M<0.01%0Timeline
SPROSPERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 889,979 shares; 2024Q4: 889,979 shares; 2025Q1: 889,979 shares; 2025Q2: 889,979 shares; 2025Q3: 889,979 shares; 2025Q4: 889,979 shares; 2026Q1: 889,979 shares; 2026Q2: 889,979 shares 889,979$1.97M<0.01%0Timeline
HYPRHYPERFINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 898,720 shares; 2024Q4: 898,720 shares; 2025Q1: 898,720 shares; 2025Q2: 898,720 shares; 2025Q3: 898,720 shares; 2025Q4: 898,720 shares; 2026Q1: 898,720 shares; 2026Q2: 898,720 shares 898,720$1.21M<0.01%0Timeline
AUTLAUTOLUS THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 698,262 shares; 2024Q4: 698,262 shares; 2025Q1: 698,262 shares; 2025Q2: 698,262 shares; 2025Q3: 698,262 shares; 2025Q4: 698,262 shares; 2026Q1: 698,262 shares; 2026Q2: 698,262 shares 698,262$1.12M<0.01%0Timeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
TNYATENAYA THERAPEUTICS INC915,705$632Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001652044-26-000073 base2026-08-07acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001652044-26-000073 Quarter ended 2026-06-302026-08-07acceptance time not in the bulk data set
13F-HR 0001652044-26-000051 Quarter ended 2026-03-312026-05-08acceptance time not in the bulk data set
13F-HR 0001652044-26-000023 Quarter ended 2025-12-312026-02-13acceptance time not in the bulk data set
13F-HR 0001652044-25-000096 Quarter ended 2025-09-302025-11-07acceptance time not in the bulk data set
13F-HR 0001652044-25-000063 Quarter ended 2025-06-302025-08-01acceptance time not in the bulk data set
13F-HR 0001652044-25-000045 Quarter ended 2025-03-312025-05-02acceptance time not in the bulk data set
13F-HR 0001652044-25-000019 Quarter ended 2024-12-312025-02-07acceptance time not in the bulk data set
13F-HR 0001652044-24-000123 Quarter ended 2024-09-302024-11-08acceptance time not in the bulk data set
13F-HR 0001652044-24-000082 Quarter ended 2024-06-302024-08-02acceptance time not in the bulk data set
13F-HR 0001652044-24-000057 Quarter ended 2024-03-312024-05-03acceptance time not in the bulk data set
13F-HR 0001652044-24-000034 Quarter ended 2023-12-312024-02-09acceptance time not in the bulk data set
13F-HR 0001652044-23-000098 Quarter ended 2023-09-302023-11-13acceptance time not in the bulk data set
13F-HR 0001652044-23-000075 Quarter ended 2023-06-302023-08-04acceptance time not in the bulk data set
13F-HR 0001652044-23-000047 Quarter ended 2023-03-312023-05-11acceptance time not in the bulk data set
13F-HR 0001652044-23-000026 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0001567619-22-020224 Quarter ended 2021-03-312022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020215 Quarter ended 2018-12-312022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020213 Quarter ended 2018-06-302022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020194 Quarter ended 2013-12-312022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020206 Quarter ended 2016-09-302022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020200 Quarter ended 2015-03-312022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020203 Quarter ended 2015-12-312022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020227 Quarter ended 2021-12-312022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020223 Quarter ended 2020-12-312022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020202 Quarter ended 2015-09-302022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020216 Quarter ended 2019-03-312022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020214 Quarter ended 2018-09-302022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020204 Quarter ended 2016-03-312022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020225 Quarter ended 2021-06-302022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020228 Quarter ended 2022-03-312022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020218 Quarter ended 2019-09-302022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020211 Quarter ended 2017-12-312022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020229 Quarter ended 2022-06-302022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020195 Quarter ended 2014-03-312022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020175 Quarter ended 2022-09-302022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020220 Quarter ended 2020-03-312022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020212 Quarter ended 2018-03-312022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020210 Quarter ended 2017-09-302022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020207 Quarter ended 2016-12-312022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020221 Quarter ended 2020-06-302022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020217 Quarter ended 2019-06-302022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020226 Quarter ended 2021-09-302022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020196 Quarter ended 2014-06-302022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020201 Quarter ended 2015-06-302022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020209 Quarter ended 2017-06-302022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020199 Quarter ended 2014-12-312022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020208 Quarter ended 2017-03-312022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020222 Quarter ended 2020-09-302022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020205 Quarter ended 2016-06-302022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020198 Quarter ended 2014-09-302022-11-15acceptance time not in the bulk data set
13F-HR 0001567619-22-020219 Quarter ended 2019-12-312022-11-15acceptance time not in the bulk data set